Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: New Hires at Omeros and Theratechnologies Plus Promotions at Alimera and Constellation
Omeros gains a new head of commercial and a VP of CMC from Celgene, while Alimera Sciences promotes its president to CEO and Constellation Pharma moves its translational sciences head to CSO.
O'Day brings Gilead experience in oncology and M&A from a large, diversified organization.
Novartis India’s managing director has quit - the second time in 2018 that the Swiss multinational finds the corner office vacated.
Executives On The Move: Bayer Adds Two New VPs and Science Leader at Janssen R&D Leaves for New Opportunity
Bayer adds new VPs in Government Relations and US Corporate Engagement from Monsanto. And at Janssen R&D, Global Head, Discovery Sciences moves to CSO position at Incyte Corp. Meanwhile, Axovant Sciences revamps its team.
Ipsen VP, Endocrinology is now CSO at metabolic and rare disease Alize Pharma, and cancer and infectious disease firm Innovio Pharmaceuticals promotes R&D leader to CSO. Plus new Head, Oncology at Nektar Therapeutics to lead area strategy.
Executives On The Move: Five Prime Fills Its CFO Slot, Myovant Appoints Chief Commercial Officer and Onconova Adds a CMO, R&D
Immuno-oncology treatment developer Five Prime Therapeutics hires a CFO, while Myovant Sciences, focused on women’s health and endocrine disease, appoints a chief commercial officer. And Onconova Therapeutics boosts its drug development expertise with addition of new CMO, R&D.
Executives On The Move: Comings And Goings This Week At Sosei And Shire, Plus An Upcoming Departure At Ferring
Sosei Group selects a new EVP, CFO and Rare Diseases VP departs Shire for Blueprint Medicines. At Ferring Pharmaceuticals, COO makes known plans to step down.
Ferring announced this morning (Oct. 31) that Michel Pettigrew is retiring as president of the executive board and will be succeeded by CSO Per Falk. The two spoke to Scrip recently and outlined the Swiss-based firm's future strategy.
Executives On The Move: Celgene Picks a Clinical Development Head And Axcella Health Gains a New CBO From Novartis
Executives On The Move: Merck & Co. Lands New Talent in Info Tech and at AstraZeneca a Global VP Will Make Tracks to Novo Nordisk
Executives On The Move: New CEOs At Perrigo And SanBio, CMOs At CardioVascular BioTherapeutics And Harpoon Therapeutics, And A Retirement At BTG
This week's company moves include a new CEO for Perrigo, while Harpoon Therapeutics and CardioVascular BioTherapeutics get new chief medical officers. And after seven years, the the chairman of BTG shares his decision to depart at end of year.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.